Here's What Key Metrics Tell Us About Allstate (ALL) Q1 Earnings

01.05.25 02:30 Uhr

Werte in diesem Artikel
Aktien

174,10 EUR 1,00 EUR 0,58%

Indizes

PKT PKT

16.371,3 PKT -120,1 PKT -0,73%

5.604,1 PKT 35,1 PKT 0,63%

Allstate (ALL) reported $16.8 billion in revenue for the quarter ended March 2025, representing a year-over-year increase of 8.9%. EPS of $3.53 for the same period compares to $5.13 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $17.13 billion, representing a surprise of -1.91%. The company delivered an EPS surprise of +56.19%, with the consensus EPS estimate being $2.26.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.Here is how Allstate performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Combined Ratio - Property-liability: 97.4% compared to the 98% average estimate based on eight analysts. Expense Ratio - Property-liability: 21.4% versus the seven-analyst average estimate of 22.5%. Loss Ratio - Property-liability: 76% versus the seven-analyst average estimate of 75.2%. Loss Ratio - Auto: 69.3% compared to the 71.5% average estimate based on six analysts. Property-Liability- Net Premiums Earned: $14.03 billion versus $14.17 billion estimated by eight analysts on average. Compared to the year-ago quarter, this number represents a +8.7% change. Property-Liability- Other Revenue: $488 million versus the seven-analyst average estimate of $485.47 million. The reported number represents a year-over-year change of +13.5%. Property-Liability- Net Investment Income: $783 million compared to the $741.90 million average estimate based on seven analysts. The reported number represents a change of +11.5% year over year. Allstate Health and Benefits- Net Investment Income: $25 million compared to the $26 million average estimate based on six analysts. The reported number represents a change of +8.7% year over year. Allstate Health and Benefits- Other Revenue: $131 million compared to the $132.46 million average estimate based on six analysts. The reported number represents a change of -2.2% year over year. Allstate Health and Benefits- Accident and health insurance premiums and contract charges: $487 million versus $491.66 million estimated by six analysts on average. Compared to the year-ago quarter, this number represents a +1.9% change. Corporate and Other- Net Investment Income: $22 million versus the six-analyst average estimate of $25.06 million. The reported number represents a year-over-year change of +22.2%. Premiums earned by brand and line of business- Allstate Protection- Homeowners: $3.66 billion compared to the $3.64 billion average estimate based on five analysts. The reported number represents a change of +16% year over year. View all Key Company Metrics for Allstate here>>>Shares of Allstate have returned -4.2% over the past month versus the Zacks S&P 500 composite's -0.2% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.Only $1 to See All Zacks' Buys and SellsWe're not kidding.Several years ago, we shocked our members by offering them 30-day access to all our picks for the total sum of only $1. No obligation to spend another cent.Thousands have taken advantage of this opportunity. Thousands did not - they thought there must be a catch. Yes, we do have a reason. We want you to get acquainted with our portfolio services like Surprise Trader, Stocks Under $10, Technology Innovators,and more, that closed 256 positions with double- and triple-digit gains in 2024 alone.See Stocks Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report The Allstate Corporation (ALL): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: Allstate und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.

Ausgewählte Hebelprodukte auf Allstate

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Allstate

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Allstate Corp.

Wer­bung

Analysen zu Allstate Corp.

DatumRatingAnalyst
15.01.2019Allstate BuyCompass Point
11.08.2017Allstate OverweightBarclays Capital
03.04.2017Allstate Mkt PerformFBR & Co.
09.05.2016Allstate BuyDeutsche Bank AG
10.08.2015Allstate BuyDeutsche Bank AG
DatumRatingAnalyst
15.01.2019Allstate BuyCompass Point
11.08.2017Allstate OverweightBarclays Capital
09.05.2016Allstate BuyDeutsche Bank AG
10.08.2015Allstate BuyDeutsche Bank AG
04.08.2015Allstate OverweightBarclays Capital
DatumRatingAnalyst
03.04.2017Allstate Mkt PerformFBR & Co.
05.08.2015Allstate NeutralCompass Point
04.08.2015Allstate Sector PerformRBC Capital Markets
07.05.2015Allstate NeutralCompass Point
31.10.2014Allstate NeutralCompass Point
DatumRatingAnalyst

Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar.

Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Allstate Corp. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen